Pharmacological approaches are not indicated for the treatment of stuttering.

Abstract

The article discusses a study aimed to determine the effectiveness of pharmacological stuttering therapies. The study was designed as a systematic review with trial quality assessment. Included studies involved pharmacological treatment of persistent developmental stuttering in any age group and where some clinical effect was intended beyond the setting of the study itself, whether or not measurements beyond the clinic were reported.